Lee Philina
Insider CIK 1845080 · BPMC Chief Commercial Officer · FUSN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 20,669 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 8,650 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 6,928 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 22,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 13,184 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-07-17 | 2025-07-21 | 21,353 | — | $0 | 63,349 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 50,165 | — | $0 | 13,184 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-03-05 | 2025-03-07 | 3,733 | $88.80 | $331.5K | 41,996 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2025-03-01 | 2025-03-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-03-01 | 2025-03-04 | 11,000 | — | $0 | 45,729 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-08-05 | 2024-08-07 | 12,350 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-08-05 | 2024-08-07 | 10,572 | — | $0 | 6,928 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-08-05 | 2024-08-07 | 8,450 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-08-05 | 2024-08-07 | 4,331 | — | $0 | 20,669 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-08-05 | 2024-08-07 | 5,011 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-08-05 | 2024-08-07 | 1,042 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2024-08-05 | 2024-08-07 | 157 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-08-05 | 2024-08-07 | 12,350 | $86.60 | $1.07M | 76,642 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-08-05 | 2024-08-07 | 10,572 | $61.31 | $648.2K | 64,292 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-08-05 | 2024-08-07 | 8,450 | $54.13 | $457.4K | 53,720 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-08-05 | 2024-08-07 | 41,913 | $93.19 | $3.91M | 34,729 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-08-05 | 2024-08-07 | 5,011 | $81.44 | $408.1K | 40,939 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-08-05 | 2024-08-07 | 1,042 | $51.06 | $53.2K | 35,928 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-08-05 | 2024-08-07 | 157 | $36.05 | $5.7K | 34,886 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-08-05 | 2024-08-07 | 4,331 | $43.15 | $186.9K | 45,270 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 17,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 30,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-13 | 2024-03-15 | 6,223 | $90.55 | $563.5K | 36,529 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-03-13 | 2024-03-15 | 523 | $8.80 | $4.6K | 41,528 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-13 | 2024-03-15 | 1,800 | $89.88 | $161.8K | 34,729 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2024-03-13 | 2024-03-15 | 1,224 | $15.01 | $18.4K | 42,752 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-07 | 2024-03-11 | 2,934 | $90.69 | $266.1K | 41,005 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-03-01 | 2024-03-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-03-01 | 2024-03-06 | 12,500 | — | $0 | 43,939 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2023-12-13 | 2024-02-14 | 261 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2023-12-13 | 2024-02-14 | 261 | $1.87 | $488 | 31,439 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2023-06-14 | 2023-06-14 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 1,622 | $45.72 | $74.2K | 31,232 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 54 | $44.40 | $2.4K | 31,178 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-03-01 | 2023-03-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-03-01 | 2023-03-03 | 12,500 | — | $0 | 32,854 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2022-06-14 | 2022-06-22 | 17,000 | — | $0 | 17,000 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2021-06-04 | 2021-06-07 | 17,000 | — | $0 | 17,000 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2021-02-11 | 2021-02-12 | 30,000 | — | $0 | 30,000 | SEC↗ |